본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Increased risk of ischemic stroke associated with elevated gamma-glutamyl transferase level in adult cancer survivors: a population-based cohort study Tae Joon Jun, Young-Hak Kim
Tae Joon Jun, Young-Hak Kim:김규웅:. Increased risk of ischemic stroke associated with elevated gamma-glutamyl transferase level in adult cancer survivors: a population-based cohort study SCIENTIFIC REPORTS. 2023-10-06; 2023; 13(1):16837~. IF 4.6 (2022)
김규웅
(호스피스질향상교육팀)
Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder in a paraneoplastic context 김호진
(신경과)
김호진:현재원:박나영, 김민정, 김수현, 김기훈, Haeun Kim. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder in a paraneoplastic context JOURNAL OF THE NEUROLOGICAL SCIENCES. 2023-10-05; 2023; 454:120825~. IF 4.4 (2022)
현재원
(신경과)
Timing of prophylactic antibiotics administration and suspected systemic infection after percutaneous biliary intervention Ho Geol Ryu
Ho Geol Ryu:임현재:Seung-Young Oh, Leerang Lim, Hannah Lee, Jina Kwon. Timing of prophylactic antibiotics administration and suspected systemic infection after percutaneous biliary intervention JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES. 2023-10-04; 2023; 31(1):34~41. IF 3 (2022)
임현재
(중환자의학과)
Questionnaire study of application about sentinel lymph node biopsy surgery in locally advanced breast cancer patients who received neoadjuvant chemotherapy 이시연
(외과)
이시연:이은경, Minjung Lee:정소연, 한재홍, 김석기. Questionnaire study of application about sentinel lymph node biopsy surgery in locally advanced breast cancer patients who received neoadjuvant chemotherapy FRONTIERS IN ONCOLOGY. 2023-10-02; 2023; 13:1235938~. IF 4.7 (2022)
이은경3
(외과)
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer 신동훈
(치료내성연구과)
신동훈:신동훈, Jeong Yeon Jo:최민영, 김경희, 배영기, 김상수. Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer EXPERIMENTAL AND MOLECULAR MEDICINE. 2023-10-02; 2023; 55(10):2220~2237. IF 12.8 (2022)
신동훈
(치료내성연구과)
Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: a multicenter retrospective study (KROG 21-10) Hak Jae Kim, Byoung Hyuck Kim
Hak Jae Kim, Byoung Hyuck Kim:문성호, Jun Yeong Song:서양권. Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: a multicenter retrospective study (KROG 21-10) RADIOTHERAPY AND ONCOLOGY. 2023-09-30; 2023; 189:109936~. IF 5.7 (2022)
문성호
(방사선의학연구과)
Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea 조유리
(표적치료연구과)
조유리:조유리:. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea INFECTIOUS DISEASES AND THERAPY. 2023-09-28; 2023; 12:2387~2403. IF 5.4 (2022)
조유리
(표적치료연구과)
Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells 김종헌
(암분자생물학연구과)
박종배
(암의생명과학과)
김종헌, 박종배:Jinlong Yin, 서유나:임지호, 김태훈, 김성수, 홍준희, 곽호신, 유헌, Xiong Jin. Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells CANCER RESEARCH. 2023-09-25; 2023; 83(22):3693~3709. IF 11.2 (2022)
서유나
(암분자생물학연구과)
Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities 강현귀
(의공학연구과)
강현귀, Yi-Jun Kim, Jin-Hong Kim:Sehan Jeong, Sharmin Afroz:김준혁, 유혜진. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities MOLECULES AND CELLS. 2023-09-22; 2023; 46(10):579~588. IF 3.8 (2022)
Sehan Jeong, Sharmin Afroz
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening Man Ki Chung
Man Ki Chung:최성용, Joonho Shim:. Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening ORAL ONCOLOGY. 2023-09-21; 2023; 146:106571~. IF 4.8 (2022)
최성용
(희귀ㆍ소아암연구과)